- Report
- October 2025
- 197 Pages
Global
From €4436EUR$4,900USD£3,807GBP
- Report
- September 2026
- 188 Pages
Global
From €3209EUR$3,545USD£2,754GBP
€3566EUR$3,939USD£3,060GBP
- Report
- January 2026
- 184 Pages
Global
From €3209EUR$3,545USD£2,754GBP
€3566EUR$3,939USD£3,060GBP
- Report
- February 2026
- 250 Pages
Global
From €4065EUR$4,490USD£3,488GBP
- Report
- July 2026
- 180 Pages
Global
From €4300EUR$4,750USD£3,690GBP
- Report
- March 2026
- 146 Pages
Global
From €3576EUR$3,950USD£3,069GBP
- Report
- August 2026
- 184 Pages
Global
From €3576EUR$3,950USD£3,069GBP
- Report
- May 2026
- 153 Pages
Global
From €3576EUR$3,950USD£3,069GBP
- Report
- February 2026
- 175 Pages
Global
From €4391EUR$4,850USD£3,768GBP
- Report
- October 2025
- 150 Pages
Global
From €4391EUR$4,850USD£3,768GBP
- Report
- December 2022
- 172 Pages
Global
From €2127EUR$2,350USD£1,826GBP
- Report
- September 2026
- 197 Pages
Global
From €3209EUR$3,545USD£2,754GBP
€3566EUR$3,939USD£3,060GBP
- Report
- October 2023
- 145 Pages
Global
From €2852EUR$3,150USD£2,447GBP
- Report
- August 2025
- 88 Pages
Global
From €3500EUR$4,142USD£3,109GBP
The Proteomic Platform market is a subset of the larger Genomics market. It focuses on the analysis of proteins, which are the building blocks of life. Proteomic Platforms are used to identify, quantify, and characterize proteins in a variety of biological samples. This technology is used to study the structure and function of proteins, as well as to identify biomarkers for disease diagnosis and drug development.
Proteomic Platforms are used in a variety of research and clinical applications, including drug discovery, biomarker discovery, and disease diagnosis. Companies in the Proteomic Platform market include Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, and Bruker Corporation. Show Less Read more
